Abstract:The element boron forms a wide range of borate minerals with different properties. Borate minerals make it possible to design boron-containing molecules with new biological properties in terms of their chemical structure and properties. It is known that boron compounds have antioxidant, anti-inflammatory, anti-tumor and anti-cancer properties. This makes boron compounds important for the future development of boron chemotherapeutics, boron supplements and new drugs. Reliable scientific studies on boron compounds will facilitate the clear presentation of their functions in its biological applications and metabolism. In this study, boron monoester and boron diester structures were synthesized with salicylic acid ligand. To stabilize boron ester structures, Na+, K+, Mg2+, Ca2+ cations were used as counter-ions. Structural properties of the synthesized substances, molecules obtained by crystallization/precipitation from aqueous solutions in solid state, elemental analysis, melting point determination, infrared spectroscopy analysis (FT-IR), thermal analysis (TGA/DTA), mass analysis (GC-MS) and single crystal analysis. Structural properties were tried to be explained by structure analysis (SC-XRD) methods. Additionally, the anticancer potential of boron salicylate esters against the MDA-MB-231 human breast adenocarcinoma cell line was examined. The K-B salicylate diester molecule was found to have the most potential potency with the lowest IC50 value against the MDA-MB-231 cell line. The anticancer potential of boron salicylate esters can be further investigated with other cancer models with the combination of anticancer drugs. It is also thought that the mechanism of action of these molecules may help reveal their further applications.

Synthesis of Boron-Containing Nucleoside Analogs

Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2'-deoxycytidine

Synthesis of new classes of boron-containing nucleotides

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology

Boron-containing nucleosides as tools for boron-neutron capture therapy

Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer

Recent developments in the medicinal chemistry of single boron atom-containing compounds

Sweet Boron: Boron-Containing Sugar Derivatives as Potential Agents for Boron Neutron Capture Therapy

Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy

Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy

Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy

Boron Chemistry for Medical Applications

Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy

Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds

Boronated thymidine analogues for boron neutron capture therapy

Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides

Boron Salicylate Ester Compounds as Boron Therapeutics. Their Synthesis, Structural Characterizations and Anticancer Effects against MDA-MB-231

Boron in cancer therapeutics: An overview

New Boron Containing Acridines: Synthesis and Preliminary Biological Study

The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry

Design and Synthesis of Bicyclo[4.3.0]nonene Nucleoside Analogues